Related Experiment Videos
A Dukes/Jass combination--is it more discriminating?
A C Haslam1, J M Pearson, D L Bisset
1Department of Surgery, Royal Bolton Hospital, Bolton, UK. alison.grey@boltonh-tr.nwest.nhs.uk
Summary
Combining the Jass staging system with the Dukes system improves colorectal cancer prognostication. This enhanced staging predicts significantly different five-year survival rates for Dukes B and C tumors.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- The Dukes staging system uses anatomical criteria for colorectal cancer.
- The Jass system incorporates biological factors like tumor margins and lymphocytic infiltration.
- This study evaluates combining Dukes and Jass staging for improved colorectal cancer prognosis.
Purpose of the Study:
- To determine if combined Dukes and Jass staging better predicts five-year survival in colorectal cancer patients than Dukes staging alone.
Main Methods:
- Data from 612 colorectal cancer patients undergoing resection (1991-1998) were analyzed.
- Dukes and Jass stages, along with five-year vital status, were recorded.
- Kaplan-Meier survival curves and log-rank tests were used for analysis.
Main Results:
- Stratifying Dukes B and C tumors by Jass group revealed significantly different five-year survival rates.
- Dukes B, Jass II tumors had 73.74% survival vs. Dukes B, Jass III at 51.38% (P=0.0018).
- Dukes C, Jass III tumors had 43.18% survival vs. Dukes C, Jass IV at 24.39% (P=0.0029).
Conclusions:
- Combining Jass biological criteria with Dukes anatomical staging improves prognostic accuracy for colorectal cancer.
- This combined approach significantly differentiates survival outcomes for Dukes B and C tumors.